Indices of nitric oxide synthesis and outcome in critically ill patients

Anaesthesia

Volumn 56, Issue 4, 2001, Pages 326-330

  Mackenzie, I M ^a,c   Garrard, C S ^b   Young, J D ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Intensive care; Multiple organ failure; Nitric oxide

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CRITICAL ILLNESS; DISEASE MARKER; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; REGRESSION ANALYSIS; SEPTIC SHOCK; SURVIVAL; THROMBOCYTE COUNT;

AGED; APACHE; BIOLOGICAL MARKERS; CYCLIC GMP; FEMALE; HUMANS; INTENSIVE CARE; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PROGNOSIS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 0035070316     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2001.01920.x     Document Type: Article

References (28)

1. Nitric oxide: Basic science and clinical applications
2. Role of endothelium-derived nitric oxide in the regulation of blood pressure
3. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
4. Incubation with endotoxin activates the L-arginine pathway in vascular tissue
5. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
6. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
7. Serial cardiovascular variables in survivors and non-survivors of human septic shock: Heart rate as an early predictor of prognosis
8. Myocardial depression characterizes the fatal course of septic shock
9. Nitrogen oxide levels in patients after trauma and during sepsis
10. L-arginine: Nitric oxide pathway in endotoxaemia and human septic shock
11. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome
12. Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock
13. Pharmacokinetic aspects of inorganic nitrate ingestion in man
14. The action and excretion of nitrates
15. Effect of renal function on serum nitrogen oxide concentrations
16. Effect of native and synthetic atrial natriuretic factor on cyclic GMP
17. Release of cyclic guanosine monophosphate as a diagnostic tool in cardiac diseases
18. Efflux of cGMP from activated human platelets
19. APACHE. II. A severity of disease classification system
20. Classification of critically ill patients based on the American College of Chest Physicians (ACCP)/Society of Critical Care Medicine (SCCM) definitions
21. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection
22. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and haemodynamic changes in human septic shock
23. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations
24. An L-arginine: Nitric oxide pathway present in human platelets regulate aggregation
25. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues
26. Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man
27. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man